Ask AI

Practical Guidance on Optimizing CLL Care in the Era of Molecular Therapies

This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other including the interactive treatment decision tool expert commentaries and an expert-authored module with downloadable slideset.

Share

Program Content

Activities

Targeted Therapies in CLL
Expert View on Managing Patients With CLL Using Targeted Therapies
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 14, 2020

Expires: February 12, 2021

Slides: Targeted Therapies in CLL
Expert View on Managing Patients With CLL Using Targeted Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 14, 2020

Expires: February 12, 2021

Activities

Updated CLL Tool
CLL Is Evolving and the Treatment Decision Support Tool Is Keeping Pace
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2019

Expires: November 11, 2020

Acalabrutinib in CLL
My Thoughts on the Recent FDA Approval of Acalabrutinib in CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 10, 2020

Expires: January 08, 2021

No activities added yet

Activities

CLL Clinician Resource
Chronic Lymphocytic Leukemia: 2019 Treatment Algorithm and Clinical Trial Spotlight
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2019

Expires: September 08, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Pharmacyclics AbbVie

Verastem Oncology

Partners

CLL Society

ProCE Banner